Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of Covid-19 on the treatment of acute myeloid leukemia.
Ferrara F, Zappasodi P, Roncoroni E, Borlenghi E, Rossi G. Ferrara F, et al. Among authors: borlenghi e. Leukemia. 2020 Aug;34(8):2254-2256. doi: 10.1038/s41375-020-0925-7. Epub 2020 Jun 19. Leukemia. 2020. PMID: 32561842 Free PMC article. No abstract available.
Fatal hemophagocytic syndrome related to active human herpesvirus-8/Kaposi sarcoma-associated herpesvirus infection in human immunodeficiency virus-negative, non-transplant patients without related malignancies.
Re A, Facchetti F, Borlenghi E, Cattaneo C, Capucci MA, Ungari M, Barozzi P, Vallerini D, Potenza L, Torelli G, Rossi G, Luppi M. Re A, et al. Among authors: borlenghi e. Eur J Haematol. 2007 Apr;78(4):361-4. doi: 10.1111/j.1600-0609.2007.00828.x. Epub 2007 Jan 22. Eur J Haematol. 2007. PMID: 17331129
Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
Cattaneo C, Quaresmini G, Casari S, Capucci MA, Micheletti M, Borlenghi E, Signorini L, Re A, Carosi G, Rossi G. Cattaneo C, et al. Among authors: borlenghi e. J Antimicrob Chemother. 2008 Mar;61(3):721-8. doi: 10.1093/jac/dkm514. Epub 2008 Jan 24. J Antimicrob Chemother. 2008. PMID: 18218645
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).
Bassan R, Spinelli O, Oldani E, Intermesoli T, Tosi M, Peruta B, Rossi G, Borlenghi E, Pogliani EM, Terruzzi E, Fabris P, Cassibba V, Lambertenghi-Deliliers G, Cortelezzi A, Bosi A, Gianfaldoni G, Ciceri F, Bernardi M, Gallamini A, Mattei D, Di Bona E, Romani C, Scattolin AM, Barbui T, Rambaldi A. Bassan R, et al. Among authors: borlenghi e. Blood. 2009 Apr 30;113(18):4153-62. doi: 10.1182/blood-2008-11-185132. Epub 2009 Jan 13. Blood. 2009. PMID: 19141862 Free article.
74 results